Double-blind crossover trial to evaluate the efficacy and safety of the bath additive containing combination of sweat-antigen-inactivating and moisturizing ingredients for atopic dermatitis
Not Applicable
- Conditions
- atopic dermatitis
- Registration Number
- JPRN-UMIN000026182
- Lead Sponsor
- Hiroshima Umiversity Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who have unstable symptoms. 2. Patients who are treated with oral steroids and/or cyclosporine. 3.Patients who have history of hypersensitivity reactions to bath additive, cosmetics, food or etc. 4.Patients who use a product having the purpose of use like examination bath additive. 5.Patients judged inappropriate for this study by the physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VAS for itch
- Secondary Outcome Measures
Name Time Method Subjective symptom(disease questionnaire) Clinical condition(objective symptom: medical examination at the department of dermatology) Total assessment Safety